Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML.
about
Lentiviral vectors in gene therapy: their current status and future potentialHematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsHematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapyModel study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7).Contributions of gene marking to cell and gene therapies.Right on target: eradicating leukemic stem cells.Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma.Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.Oncolytic virotherapy for hematological malignancies.High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.Genetic engineering: moral aspects and control of practiceResults of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapyAutografting as first line treatment for chronic myeloid leukaemia.Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies.Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche.Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow.Oncolytic virotherapy for multiple myeloma: past, present, and future.Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296.A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants.Detection of minimal residual disease in hematopoietic progenitor cell harvests: lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma.
P2860
Q24629462-EC162A8C-BDA6-49F0-86DE-A624D8061DD5Q26859147-E64272F2-D288-44AD-8F67-7D2AE3764B8CQ34302673-E26F6813-FF18-4345-B5EC-AC843D394430Q34777677-BA38D2F5-298D-429D-8C31-2C91F7381E8EQ35059829-4AC57C78-8525-47C1-88F4-4650FBEA1D3CQ35132225-E8F40912-76EF-4B28-9C63-CF84BD767254Q35213839-BF6A6B39-2BE3-495B-B9DC-C49091CE45F5Q35633858-9387AB10-6D33-4BEB-9620-7819961F23C5Q35692095-04418074-9B21-45D4-9CEC-7ECB988FABC1Q36115468-9A74EB33-E086-4E71-8689-34B75ADADFE9Q36267781-C49FB16D-E7BE-440E-82DA-727A414BFAECQ37093518-2ADBA7C7-E824-47F3-85F2-AB1FB939D20DQ37217601-463C8E56-0F59-480D-B3CA-8959AE00CBABQ37410746-83A8842B-D86F-4B99-9891-46A7FA634386Q37609426-6875EB18-1CBF-451D-BD41-3F0E99F6E41BQ38318142-25D17F33-0DF8-474B-860F-B6E1B25EA2B3Q38803056-52C1B29D-BB35-4837-9A13-4AB854E87C94Q39550466-2CFF0E3F-F379-4DB6-AB1F-4FC768F480BEQ40307186-5CDBF869-1CA4-4458-80A1-4C578C80DA7FQ42216639-C810FE71-FB4F-44CA-9792-41B6D1DC012F
P2860
Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Genetic marking shows that Ph+ ...... autologous bone marrow in CML.
@en
Genetic marking shows that Ph+ ...... f chronic myelogenous leukemia
@nl
type
label
Genetic marking shows that Ph+ ...... autologous bone marrow in CML.
@en
Genetic marking shows that Ph+ ...... f chronic myelogenous leukemia
@nl
prefLabel
Genetic marking shows that Ph+ ...... autologous bone marrow in CML.
@en
Genetic marking shows that Ph+ ...... f chronic myelogenous leukemia
@nl
P2093
P1433
P1476
Genetic marking shows that Ph+ ...... autologous bone marrow in CML.
@en
P2093
Anderson WF
Deisseroth AB
Ellerson D
Goldberg L
Hanania EG
P304
P407
P577
1994-05-01T00:00:00Z